These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6772231)

  • 1. Studies on factor VIII-related protein. IV. Interaction of galactose-specific lectins with human factor VIII/Von Willebrand factor.
    Furlan M; Perret BA; Beck EA
    Biochim Biophys Acta; 1980 Jun; 623(2):402-11. PubMed ID: 6772231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is there a correlation between sugar content, thrombocyte aggregating activity and molecular size of factor VIII?].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1369-70. PubMed ID: 314662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues.
    Sodetz JM; Paulson JC; Pizzo SV; McKee PA
    J Biol Chem; 1978 Oct; 253(20):7202-6. PubMed ID: 100492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation.
    Federici AB; Elder JH; De Marco L; Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1984 Dec; 74(6):2049-55. PubMed ID: 6239876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.
    Gralnick HR
    J Clin Invest; 1978 Aug; 62(2):496-9. PubMed ID: 307560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective binding of the factor VIII/von Willebrand factor protein to human platelets.
    Morisato DK; Gralnick HR
    Blood; 1980 Jan; 55(1):9-15. PubMed ID: 6965350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
    Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M
    Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin affinity high-performance liquid chromatography. Interactions of N-glycanase-released oligosaccharides with Ricinus communis agglutinin I and Ricinus communis agglutinin II.
    Green ED; Brodbeck RM; Baenziger JU
    J Biol Chem; 1987 Sep; 262(25):12030-9. PubMed ID: 3624246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
    Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
    Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Clin Invest; 1979 Apr; 63(4):656-64. PubMed ID: 108291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neuraminidase and papain treatment on lectin-induced agglutination of Novikoff tumor cells and assay of lectin receptor activity of the glycopeptides released from the cell surface by papain.
    Neri G; Giuliano MC; Capetillo S; Gilliam EB; Hixson DC; Walborg EF
    Cancer Res; 1976 Jan; 36(1):263-8. PubMed ID: 174811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
    Counts RB; Paskell SL; Elgee SK
    J Clin Invest; 1978 Sep; 62(3):702-9. PubMed ID: 308512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII/von Willebrand factor has potent lectin activity.
    Booth WJ; Furby FH; Berndt MC; Castaldi PA
    Biochem Biophys Res Commun; 1984 Jan; 118(2):495-501. PubMed ID: 6422929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of von Willebrand factor: effects of different kinds of carbohydrate oxidases, SH-inhibitors and some other chemical reagents.
    Fukui H; Mikami S; Okuda T; Murashima N; Takase T
    Br J Haematol; 1977 Jun; 36(2):259-70. PubMed ID: 301402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.